Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
0.7245
-0.0149 (-2.02%)
At close: May 30, 2025, 4:00 PM
0.7400
+0.0155 (2.14%)
After-hours: May 30, 2025, 6:44 PM EDT
Nektar Therapeutics Stock Forecast
Stock Price Forecast
According to 6 professional analysts, the 12-month price target for Nektar Therapeutics stock ranges from a low of $2.00 to a high of $7.00. The average analyst price target of $4.92 forecasts a 579.09% increase in the stock price over the next year.
Price Target: $4.92 (+579.09%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 11, 2025.
Analyst Ratings
The average analyst rating for Nektar Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 3 | 3 | 3 | 4 | 4 |
| Buy | 2 | 1 | 1 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 0 | 0 | 0 |
| Sell | 1 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $1 → $2 | Hold → Strong Buy | Upgrades | $1 → $2 | +176.05% | Apr 11, 2025 |
| Oppenheimer | Oppenheimer | Hold → Buy Upgrades $6 | Hold → Buy | Upgrades | $6 | +728.16% | Mar 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6.5 | Strong Buy | Reiterates | $6.5 | +797.17% | Mar 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6.5 | Strong Buy | Reiterates | $6.5 | +797.17% | Feb 25, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6.5 | Strong Buy | Reiterates | $6.5 | +797.17% | Jan 13, 2025 |
Financial Forecast
Revenue This Year
56.99M
from 98.43M
Decreased by -42.10%
Revenue Next Year
53.36M
from 56.99M
Decreased by -6.36%
EPS This Year
-0.79
from -0.58
EPS Next Year
-0.84
from -0.79
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 131.4M | 139.4M | 138.9M | ||
| Avg | 57.0M | 53.4M | 56.1M | ||
| Low | 39.2M | 23.5M | 7.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 33.5% | 144.6% | 160.4% | ||
| Avg | -42.1% | -6.4% | 5.1% | ||
| Low | -60.2% | -58.7% | -85.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.64 | -0.55 | -0.39 | ||
| Avg | -0.79 | -0.84 | -0.94 | ||
| Low | -0.95 | -1.32 | -1.86 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.